Listed

Central Garden & Pet Co: Form 10-Q for the period ended Mar 30, 2019

Filed with the SEC on May 7, 2019 and accepted by EDGAR at May 7, 2019, 15:04 ET.

Share

Management's discussion and analysis

As filed, 55,914 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Our Company

Central Garden & Pet Company (“Central”) is a leading innovator, producer and distributor of branded and private label products for the lawn & garden and pet supplies markets in the United States. The total annual retail sales of the pet food, treats & chews, supplies and live animal industry in 2017 was estimated by Packaged Facts and the pet industry to have been approximately $58.3 billion. We estimate the annual retail sales of the pet supplies, live animal, and treats & chews and natural pet food markets in the categories in which we participate to be approximately $27.3 billion. The total lawn and garden consumables, decorative products and live plant industry in the United States is estimated by Packaged Facts and IBISWorld to be approximately $33.2 billion in annual retail sales in 2017, including fertilizer, pesticides, growing media, seeds, mulch, other consumables, decorative products and live plants. We estimate the annual retail sales of the lawn and garden consumables, decorative products and live plant markets in the categories in which we participate to be approximately $19.7 billion.

Our pet supplies products include products for dogs and cats, including edible bones, premium healthy edible and non-edible chews, natural dog and cat food and treats, toys, pet carriers, grooming supplies and other accessories; products for birds, small animals and specialty pets, including food, cages and habitats, toys, chews and related accessories; animal and household health and insect control products; live fish and products for fish, reptiles and other aquarium-based pets, including aquariums, furniture and lighting fixtures, pumps, filters, water conditioners, food and supplements, and information and knowledge resources; and products for horses and livestock. These products are sold under the brands Adams™, Aqueon®, Avoderm®, Cadet®, Farnam®, Four Paws®, Kaytee®, K&H Pet Products®, Nylabone®, Pinnacle®, TFH™, Zilla® as well as a number of other brands including Altosid®, Comfort Zone®, Coralife®, Interpet®, Kent Marine®, Pet Select® and Zodiac®.

Our lawn and garden supplies products include proprietary and non-proprietary grass seed; wild bird feed, bird feeders, bird houses and other birding accessories; weed, grass, and other herbicides, insecticide and pesticide products; fertilizers; and decorative outdoor lifestyle products including pottery and wood products as well as live plants. These products are sold under the brands AMDRO®, Ironite®, Pennington®, and Sevin®, as well as a number of other brand names including Lilly Miller®, Over-N-Out®, Smart Seed® and The Rebels®.

In fiscal 2018, our consolidated net sales were $2,215 million, of which our Pet segment, or Pet, accounted for approximately $1,341 million and our Garden segment, or Garden, accounted for approximately $874 million. In fiscal 2018, our operating income was $167 million consisting of income from our Pet segment of $140 million, income from our Garden segment of $96 million and corporate expenses of $69 million.

We were incorporated in Delaware in May 1992 as the successor to a California corporation that was formed in 1955. Our executive offices are located at 1340 Treat Boulevard, Suite 600, Walnut Creek, California 94597, and our telephone number is (925) 948-4000. Our website is www.central.com (http://www.central.com). The information on our website is not incorporated by reference in this annual report.

Recent Developments

Fiscal 2019 Second Quarter Financial Performance:

  • Net sales increased $60.6 million, or 9.9%, from the prior year quarter to $673.7 million due primarily to the inclusion of three acquisitions that were not part of the second quarter fiscal 2018 results. Pet segment sales increased $16.5 million, and Garden segment sales increased $44.1 million.
  • Organic net sales increased 2.1%. Organic net sales were relatively flat in our Pet segment and increased 4.4% in our Garden segment.
  • Gross profit increased $11.6 million, although gross margin declined 110 basis points to 30.6%, due primarily to the three acquisitions.
  • Selling, general & administrative expense increased $15.2 million to $143.9 million.
  • Operating income declined $3.6 million, from the prior year quarter, to $62.2 million in the second quarter of fiscal 2019.
  • Our net income in the second quarter of fiscal 2019 was $42.4 million, or $0.73 per diluted share, compared to $45.2 million, or $0.86 per diluted share, in the second quarter of fiscal 2018. On a non-GAAP basis, adjusted net income per diluted share in the second quarter of fiscal 2019 was $0.72 compared to $0.86 per diluted share in the second quarter of fiscal 2018.

Arden Companies

In February 2019, the Company purchased the remaining 55% interest in Arden Companies, a manufacturer of outdoor cushions and pillows, for approximately $13.4 million. The Company remeasured its previously held investment interest at the acquisition date fair value and recorded a provisional non-cash gain of approximately $3.2 million as part of selling, general and administrative expense. Subsequent to the acquisition, approximately $36 million was used to eliminate most of the acquired long-term debt.

Intangible Asset Impairment

As a result of one of our retail customers exiting the live fish business, we recorded a non-cash $2.5 million intangible asset impairment within our live fish business, acquired in 2016, as part of selling, general and administrative expense.

Results of Operations

Three Months Ended March 30, 2019

Compared with Three Months Ended March 31, 2018

Net Sales

Net sales for the three months ended March 30, 2019 increased $60.6 million, or 9.9%, to $673.7 million from $613.1 million for the three months ended March 31, 2018. Organic net sales, which excludes the impact of acquisitions and divestitures in the last 12 months, increased $13.0 million, or 2.1%, as compared to the fiscal 2018 quarter. Our branded product sales increased $45.6 million, and sales of other manufacturers’ products increased $15.0 million.

Pet net sales increased $16.5 million, or 5.1%, to $338.2 million for the three months ended March 30, 2019 from $321.7 million for the three months ended March 31, 2018. The increase in net sales was due primarily to sales from our acquisition of General Pet Supply in fiscal 2018. Organic net sales were relatively flat, increasing $0.2 million. Increased sales in our live fish and our dog and cat businesses were partially offset by a decline in animal health sales. The increases were primarily volume-based but price increases effective in 2019 were also a contributing factor. One of our retail customers is exiting the live fish category, and we expect our live fish business to have lower sales for the remainder of fiscal 2019. The decline in our animal health sales was due primarily to lower sales of pet behavior modification products, impacted by a new market entrant and product performance issues, and professional products, impacted by weather and inventory challenges. Pet branded product sales increased $2.6 million, and sales of other manufacturers' products increased $13.9 million.

Garden net sales increased $44.1 million, or 15.1%, to $335.5 million for the three months ended March 30, 2019 from $291.4 million for the three months ended March 31, 2018. The increase in net sales was due to sales from recent acquisitions of $31.3 million and higher organic sales, which increased $12.8 million, or 4.4%. We acquired Bell Nursery in fiscal 2018 and Arden in fiscal 2019. The increase in organic sales was due primarily to increased sales in grass seed, which benefited from the launch of a new product, and wild bird feed. The increased sales were primarily volume-based but were also positively impacted by price increases in 2019. Garden branded sales increased $43.0 million, due to acquisitions and organic growth, and sales of other manufacturers' products increased $1.1 million.

Gross Profit

Gross profit for the three months ended March 30, 2019 increased $11.6 million, or 6.0%, to $206.1 million from $194.5 million for the three months ended March 31, 2018. Both the Pet and Garden segments contributed to the increase in gross profit. Gross margin declined 110 basis points to 30.6% for the three months ended March 30, 2019 from 31.7% for the three months ended March 31, 2018, due primarily to the impact of our three recent acquisitions.

The gross profit increase in Pet was due primarily to the acquisition of General Pet supply in fiscal 2018 and the price increases taken in 2019 to offset increased costs. The Pet gross margin improvement was due primarily to the pricing actions taken to offset increased costs and increased sales in our dog and cat business, partially offset by the lower gross margin of the General Pet supply distribution business acquired in the third quarter of fiscal 2018.

The gross profit increase in Garden was due to the organic sales increase and the acquisition of Arden in February 2019. Gross margin decreased due primarily to our acquisitions of Bell Nursery and Arden and increased grass seed commodity costs. The second quarter is unprofitable for our live-plant business, Bell Nursery, which only earns a profit in our third fiscal quarter. The Arden gross margin was negatively impacted by the mark-up of the acquired inventory resulting from purchase price accounting.

Selling, General and Administrative Expenses

Selling, general and administrative expenses increased $15.2 million, or 11.8%, to $143.9 million for the three months ended March 30, 2019 from $128.7 million for the three months ended March 31, 2018. Selling, general and administrative expenses increased in both operating segments, due primarily to businesses acquired in the last 12 months. As a percentage of net sales, selling, general and administrative expenses increased to 21.4% for the three months ended March 30, 2019, compared to 21.0% in the comparable prior year quarter.

Selling and delivery expense increased $2.3 million, or 3.3%, to $71.9 million for the three months ended March 30, 2019 from $69.6 million for the three months ended March 31, 2018. Selling and delivery expense increased due primarily to our three recent acquisitions and increased delivery expenses due to higher transportation costs.

Warehouse and administrative expense increased $12.9 million, or 21.8%, to $72.0 million for the three months ended March 30, 2019 from $59.1 million for the three months ended March 31, 2018 primarily due to our three recent acquisitions. Corporate expenses increased due primarily to expenses to implement the new GAAP lease standard we will adopt beginning fiscal 2020. Corporate expenses are included within administrative expense and relate to the costs of unallocated executive, administrative, finance, legal, human resources, and information technology functions.

Operating Income

Operating income decreased $3.6 million to $62.2 million for the three months ended March 30, 2019 from $65.8 million for the three months ended March 31, 2018. The decreased operating income and lower operating margin were attributable to a lower gross margin and increased selling, general and administrative expense as a percentage of net sales. Excluding the impact of our three recent acquisitions and the intangible asset impairment charge, operating income increased for the quarter ended March 30, 2019. Operating margin decreased to 9.2% for the three months ended March 30, 2019 from 10.7% for the three months ended March 31, 2018 due to a 110 basis point decline in gross margin, and a 40 basis point increase in selling, general and administrative expense as a percentage of net sales, both impacted by our three recent acquisitions, in the current year quarter.

Pet operating income decreased $5.8 million, or 17.7%, to $27.0 million for the three months ended March 30, 2019 from $32.8 million for the three months ended March 31, 2018. Increased sales of $16.5 million were more than offset by a lower gross margin and increased selling, general and administrative expense, which includes a $2.5 million non-cash intangible asset impairment charge. Pet operating margin decreased to 8.0% for the three months ended March 30, 2019 from 10.2% for the three months ended March 31, 2018 due to the impact of our acquisition of General Pet Supply, a distribution business with lower operating margins than our manufacturing businesses, a less favorable mix of organic sales due primarily to the animal health sales decrease, higher transportation costs and a $2.5 million non-cash intangible asset impairment charge within our live fish business.

Garden operating income increased $2.7 million, or 5.1%, to $53.4 million for the three months ended March 30, 2019 from income of $50.7 million for the three months ended March 31, 2018. Garden non-GAAP operating income decreased $0.6 million, or 1.2%, to $50.1 million for the three months ended March 30, 2019 from $50.7 million for the three months ended March 31, 2018, as increased sales were offset by a lower gross margin and increased selling, general and administrative expenses. The decrease in Garden operating income was due to our recent acquisition of Bell Nursery. Bell Nursery is in the live garden goods business and is subject to extreme seasonality, only generating income in the third quarter while typically incurring losses in the other three quarters.

Corporate operating expense increased $0.5 million to $18.2 million in the current year quarter from $17.7 million in the fiscal 2018 quarter due primarily to expenses incurred to implement the new GAAP lease standard.

Net Interest Expense

Net interest expense for the three months ended March 30, 2019 decreased $1.5 million, or 15.1%, to $8.4 million from $9.9 million for the three months ended March 31, 2018. The decrease in net interest expense was due to increased interest income from earnings on excess cash due to our higher cash balance during the quarter.

Debt outstanding on March 30, 2019 was $697.8 million compared to $691.1 million at March 31, 2018.

Other Income

Other income is comprised of income or losses from investments accounted for under the equity method of accounting and foreign currency exchange gains and losses. Other income decreased $1.0 million to $0.5 million for the quarter ended March 30, 2019, from $1.5 million for the quarter ended March 31, 2018. The decrease in other income was due primarily to our purchase of the remaining 55% ownership interest in Arden in February 2019. Consequently, the second quarter of fiscal 2019 includes only one month of equity method earnings for Arden compared to three months included in the fiscal 2018 quarter.

Income Taxes

Our effective income tax rate was 21.3% for the quarter ended March 30, 2019 compared 20.3% for the quarter ended March 31, 2018. The higher effective income tax rate in the current year quarter was due primarily to lower excess tax benefits from stock compensation in the current year quarter. We believe this will continue for the remainder of fiscal 2019 resulting in a higher effective income tax rate for the remaining quarters as compared to the prior year quarters, excluding the impact of the Tax Reform Act on our deferred tax accounts in fiscal 2018.

Net Income and Earnings Per Share

Our net income in the second quarter of fiscal 2019 was $42.4 million, or $0.73 per diluted share, compared to $45.2 million, or $0.86 per diluted share, in the second quarter of fiscal 2018. Adjusting for the non-cash gain from the fair value remeasurement of our previously held investment interest upon our acquisition of the remaining 55% interest of Arden and for the non-cash charge for the intangible asset impairment in our Pet segment, our non-GAAP net income in the second quarter of fiscal 2019 was $41.9 million, or $0.72 per diluted share, compared to $0.86 per diluted share in the prior year quarter.

Six Months Ended March 30, 2019

Compared with Six Months Ended March 31, 2018

Net Sales

Net sales for the six months ended March 30, 2019 increased $80.6 million, or 7.6%, to $1,135.7 million from $1,055.1 million for the six months ended March 31, 2018. Organic net sales increased $5.7 million, or 0.5%, as compared to the prior year six month period. Our branded product sales increased $50.1 million, and sales of other manufacturers’ products increased $30.5 million.

Pet net sales increased $31.9 million, or 4.9%, to $678.6 million for the six months ended March 30, 2019 from $646.7 million for the six months ended March 31, 2018. The increase in net sales was due to sales from our acquisition of General Pet Supply in fiscal 2018. Organic net sales declined $1.6 million, or 0.2%, due primarily to lower sales in our animal health business due to lower sales of pet behavior modification products, impacted by a new market entrant and product performance issues, and a soft flea and tick season and lower sales into the professional channel due to weather and inventory challenges. The decrease in animal health was partially offset by increased sales in our live fish and dog and cat businesses. Pet branded sales increased $1.6 million, and sales of other manufacturer's products increased $30.3 million.

Garden net sales increased $48.7 million, or 11.9%, to $457.1 million for the six months ended March 30, 2019 from $408.4 million for the six months ended March 31, 2018. The increase in net sales was due to both sales of $41.4 million from our recent acquisitions, Bell Nursery in fiscal 2018 and Arden in fiscal 2019, and a $7.3 million increase in organic net sales. The increase in organic sales was due primarily to increased sales in grass seed, which benefited from the launch of a new product, 2019 price increases, and volume-based increases in wild bird feed sales. These increases were partially offset by decreased sales in our controls and fertilizer products due to the timing of orders. Garden branded sales increased $48.5 million, and sales of other manufacturers’ products increased $0.2 million.

Gross Profit

Gross profit for the six months ended March 30, 2019 increased $9.9 million, or 3.0%, to $336.2 million from $326.3 million for the six months ended March 31, 2018. The Pet segment was the primary driver of the gross profit increase, although both operating segments contributed to the increased gross profit. Gross margin decreased 130 basis points to 29.6% for the six months ended March 30, 2019 from 30.9% for the six months ended March 31, 2018. The gross margin decrease was primarily attributable to Garden although Pet had a minor decline in gross margin. The gross margin for the six month period was negatively impacted by the lack of price increases in our fiscal first quarter as the price increases predominantly did not go into effect until our fiscal second quarter of 2019.

In the Pet segment, the acquisition of General Pet Supply positively impacted Pet’s gross profit due to the increase in net sales but negatively impacted Pet’s gross margin as it is a distribution business and operates with lower margins. The decline in our animal health sales also had an adverse impact on Pet’s gross margin due to the lower sales volume and its impact on Pet’s sales mix.

In the Garden segment, the acquisition of Arden positively impacted Garden’s gross profit due to the increase in net sales. The Garden gross margin was negatively impacted by the acquisitions of Bell Nursery and Arden, as well as the impact of the lower sales volume in our controls and fertilizer business.

Selling, General and Administrative Expenses

Selling, general and administrative expenses increased $25.9 million, or 10.9%, to $263.9 million for the six months ended March 30, 2019 from $238.0 million for the six months ended March 31, 2018. As a percentage of net sales, selling, general and administrative expenses increased to 23.2% for the six months ended March 30, 2019, from 22.6% for the comparable prior year six month period. Both operating segments reflected increased selling, general and administrative expenses in the current year six month period as compared to the prior year six month period.

Selling and delivery expense increased $9.1 million, or 7.4%, to $132.6 million for the six months ended March 30, 2019 from $123.5 million for the six months ended March 31, 2018. The increase was due primarily to recent acquisitions and secondarily to increased delivery expenses resulting from increased freight costs.

Warehouse and administrative expense increased $16.8 million, or 14.7%, to $131.3 million for the six months ended March 30, 2019 from $114.5 million for the six months ended March 31, 2018. Increased expense in both operating segments was due primarily to our three recent acquisitions. The decrease at Corporate was due primarily to lower medical insurance costs partially offset by expenses incurred to implement the new GAAP lease standard we will adopt beginning fiscal 2020. Corporate expenses are included within administrative expense and relate to the costs of unallocated executive, administrative, finance, legal, human resource, and information technology functions.

Operating Income

Operating income decreased $16.0 million to $72.3 million for the six months ended March 30, 2019 from $88.3 million for the six months ended March 31, 2018. Our operating margin declined to 6.4% for the six months ended March 30, 2019 from 8.4% for the six months ended March 31, 2018. Increased sales of $80.6 million, were more than offset by a 130 basis point decline in gross margin and a 60 basis point increase in selling, general and administrative expense as a percent of net sales. Adjusting for the non-cash gain from the fair value remeasurement of our previously held investment interest upon our acquisition of the remaining 55% interest of Arden and for the non-cash charge for the intangible asset impairment in our Pet segment, our non-GAAP operating income decreased $16.6 million to $71.7 million for the six months ended March 30, 2019 from $88.3 million for the six months ended March 31, 2018.

Pet operating income declined $12.3 million, or 17.8%, to $56.7 million for the six months ended March 30, 2019 from $69.0 million for the six months ended March 31, 2018. Adjusting for the $2.5 million intangible asset impairment in fiscal 2019, operating income decreased $9.7 million and the operating margin was 8.7% for the six months ended March 30, 2019. The decrease was due to a lower gross margin and higher selling, general and administrative expense due primarily to our acquisition of General Pet Supply and the decreased sales and its impact on margin and mix in our animal health business.

Garden operating income declined $4.3 million, or 8.1%, to $48.7 million for the six months ended March 30, 2019 from $53.0 million in the six months ended March 31, 2018. Adjusting for the non-cash gain from the fair value remeasurement of our previously held investment interest upon our acquisition of the remaining 55% interest of Arden, operating income decreased $7.5 million to $45.5 million in the six month period ended March 30, 2019 compared to $53.0 million in the six month period ended March 31, 2018. The decrease in operating income was due primarily to our Bell Nursery acquisition and the decrease in operating margin due to both of our recent acquisitions.

Corporate operating expenses decreased $0.6 million to $33.1 million in the current six month period from $33.7 million in the comparable fiscal 2018 period due primarily to decreased medical insurance expense.

Net Interest Expense

Net interest expense for the six months ended March 30, 2019 decreased $0.6 million, or 3.7%, to $16.5 million from $17.1 million for the six months ended March 31, 2018. Increased interest expense incurred in our fiscal 2019 first quarter, due to higher average debt outstanding, was more than offset by increased interest income in our fiscal 2019 second quarter. In December 2017, we issued $300 million aggregate principal amount of 5.125% senior notes due February 2028.

Debt outstanding on March 30, 2019 was $697.8 million compared to $691.1 million as of March 31, 2018. Our average borrowing rate for the current six month period was 5.8% compared to from 5.7% for the prior year six month period.

Other Income

Other income increased $1.9 million to income of $0.3 million for the six months ended March 30, 2019, from an expense of $1.6 million for the six months ended March 31, 2018. Lower losses from one of our start-up business investments were partially offset by lower income from Arden due to our purchase of the remaining 55% ownership interest in February 2019. Other expense is comprised of income or losses from investments accounted for under the equity method of accounting and foreign currency exchange gains and losses.

Income Taxes

Our effective income tax rate was 21.0% for the six month period ended March 30, 2019 compared to an income tax benefit for the six month period ended March 31, 2018. The prior year six month period included a provisional tax benefit of $16.3 million, due to the remeasurement of our deferred tax accounts upon the enactment of the Tax Reform Act.

In the prior year six month period, after adjusting for the provisional tax benefit of $16.3 million, our effective income tax rate was 19.7% compared to our effective income tax rate of 21.0% in the current year six month period. The higher effective income tax rate in the current year quarter was due primarily to lower excess tax benefits from stock compensation in the current year quarter.

Net Income and Earnings Per Share

Our net income for the six months ended March 30, 2019 was $44.2 million, or $0.76 per diluted share, compared to $71.5 million, or $1.36 per diluted share, for the six months ended March 31, 2018.

In the prior year six month period, the provisional impact of the Tax Reform Act on our deferred tax accounts was significant. Adjusting the six month period ended March 30, 2019 for the non-cash gain from the fair value remeasurement of our previously held investment interest upon our acquisition of the remaining 55% interest of Arden and for the non-cash charge for the intangible asset impairment in our Pet segment and the six month period ended March 31, 2018 for the provisional impact of the Tax Reform Act on our deferred tax accounts, non-GAAP net income for the fiscal 2019 six month period was $43.7 million, or $0.75 per diluted share, compared to $55.1 million, or $1.05 per diluted share in the fiscal 2018 six month period. The decline in the six month period in net income and earnings per share were due primarily to our acquisition of Bell Nursery, which is highly seasonal and incurred losses in the first and second quarters of fiscal 2019, which were not part of our prior year period, and increased shares outstanding due to our prior year equity offering.

Use of Non-GAAP Financial Measures

We report our financial results in accordance with U.S. generally accepted accounting principles (GAAP). However, to supplement the financial results prepared in accordance with GAAP, we use non-GAAP financial measures including non-GAAP net sales and operating income on a consolidated and segment basis, and non-GAAP net income and diluted net income per share. Management believes these non-GAAP financial measures that exclude the impact of specific items (described below) may be useful to investors in their assessment of our ongoing operating performance and provide additional meaningful comparisons between current results and results in prior operating periods.

EBITDA is defined by us as income before income tax, net other expense, net interest expense and depreciation and amortization. We present EBITDA because we believe that EBITDA is a useful supplemental measure in evaluating the cash flows and performance of our business and provides greater transparency into our results of operations. EBITDA is used by our management to perform such evaluation. EBITDA should not be considered in isolation or as substitutes for cash flow from operations, income from operations or other income statement measure prepared in accordance with GAAP. We believe that EBITDA is frequently used by investors, securities analysts and other interested parties in their evaluation of companies, many of which present EBITDA when reporting their results. Other companies may calculate EBITDA differently, it may not be comparable.

We have also provided organic net sales, a non-GAAP measure that excludes the impact of businesses purchased or exited in the prior 12 months, because we believe it permits investors to better understand the performance of our historical business without the impact of recent acquisitions or dispositions.

The reconciliations of these non-GAAP measures to the most directly comparable financial measures calculated and presented in accordance with GAAP are shown in the tables below. We believe that the non-GAAP financial measures provide useful information to investors and other users of our financial statements, by allowing for greater transparency in the review of our financial and operating performance. Management also uses these non-GAAP financial measures in making financial, operating and planning decisions and in evaluating our performance, and we believe these measures similarly may be useful to investors in evaluating our financial and operating performance and the trends in our business from management's point of view. While our management believes that non-GAAP measurements are useful supplemental information, such adjusted results are not intended to replace our GAAP financial results and should be read in conjunction with those GAAP results.

Non-GAAP financial measures reflect adjustments based on the following items:

  • Gains from the fair value remeasurement of previously held investment interests: we have excluded the impact of the fair value remeasurement of a previously held investment interest as it represents an infrequent transaction that occurs in limited circumstances that impacts the comparability between operating periods. We believe the adjustment of these gains supplements the GAAP information with a measure that may be used to assess the sustainability of our operating performance.
  • Asset impairment charges: we have excluded the impact of asset impairments on intangible assets as such non-cash amounts are inconsistent in amount and frequency. We believe that the adjustment of these charges supplements the GAAP information with a measure that can be used to assess the sustainability of our operating performance.
  • The U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Job Act (the "Tax Reform Act") in December 2017. We have excluded the transitional impact of the Tax Reform Act as the remeasurement of our deferred tax assets and liabilities does not reflect the ongoing impact of the lower U.S. statutory rate on our current year or future year earnings.

From time to time in the future, there may be other items that we may exclude if we believe that doing so is consistent with the goal of providing useful information to investors and management.

The non-GAAP adjustments reflect the following:

(1) During the second quarter of fiscal 2019, we recorded a preliminary, pending the finalization of the related purchase accounting, non-cash $3.2 million gain in our Garden segment from the fair value remeasurement of our previously held 45% interest in Arden upon our acquisition of the remaining 55% interest. The gain was recorded as part of selling, general and administrative costs in the condensed consolidated statements of operations.

(2) During the second quarter of fiscal 2019, we recognized a non-cash impairment charge in our Pet segment of $2.5 million related to the impairment of intangible assets caused by a retail customer exiting the live fish business. The adjustment was recorded as part of selling, general and administrative costs.

(3) Transitional impact of U.S. Tax Reform: As a result of the Tax Reform Act, the Company recorded a provisional tax benefit of $16.3 million in the quarter ended December 30, 2017, due to the remeasurement of its deferred tax assets and liabilities. We have excluded only this transitional impact and have not included in the adjustment the ongoing impact of the lower U.S. statutory rate on our current or future year earnings.

Operating Income Reconciliation GAAP to Non-GAAP Reconciliation (in thousands) For the Three Months Ended Consolidated March 30, 2019 March 31, 2018 GAAP to Non-GAAP Reconciliation (in thousands) For the Six Months Ended Consolidated March 30, 2019 March 31, 2018
GAAP operating income $62,153 $65,786 $72,334 $88,307
Previously held investment interest fair value remeasurement (1) (3,215) — (3,215) —
Intangible asset impairment (2) 2,540 — 2,540 —
Non-GAAP operating income $61,478 $65,786 $71,659 $88,307

38

Pet Segment Operating Income Reconciliation GAAP to Non-GAAP Reconciliation (in thousands) For the Three Months Ended Pet March 30, 2019 March 31, 2018 GAAP to Non-GAAP Reconciliation (in thousands) For the Six Months Ended Pet March 30, 2019 March 31, 2018
GAAP operating income $26,984 $32,784 $56,739 $68,960
Intangible asset impairment (2) 2,540 — 2,540 —
Non-GAAP operating income $29,524 $32,784 $59,279 $68,960
Garden Segment Operating Income Reconciliation GAAP to Non-GAAP Reconciliation (in thousands) For the Three Months Ended Garden March 30, 2019 March 31, 2018 GAAP to Non-GAAP Reconciliation (in thousands) For the Six Months Ended Garden March 30, 2019 March 31, 2018
GAAP operating income $53,355 $50,746 $48,718 $53,046
Previously held investment interest fair value remeasurement (1) (3,215) — (3,215) —
Non-GAAP operating income $50,140 $50,746 $45,503 $53,046
Net Income and Diluted Net Income Per Share Reconciliation GAAP to Non-GAAP Reconciliation (in thousands, except per share amounts) For the Three Months Ended March 30, 2019 March 31, 2018
GAAP net income attributable to Central Garden & Pet $42,391 $45,234
Previously held investment interest fair value remeasurement (1) (3,215) —
Intangible asset impairment (2) 2,540 —
Tax effect of remeasurement and impairment 144 —
Non-GAAP net income attributable to Central Garden & Pet 41,860 45,234
GAAP diluted net income per share $0.73 $0.86
Non-GAAP diluted net income per share $0.72 $0.86
Shares used in GAAP and non-GAAP diluted net earnings per share calculation 58,026 52,658
Net Income and Diluted Net Income Per Share Reconciliation GAAP to Non-GAAP Reconciliation (in thousands, except per share amounts) For the Six Months Ended March 30, 2019 March 31, 2018
GAAP net income attributable to Central Garden & Pet $44,194 $71,481
Previously held investment interest fair value remeasurement (1) (3,215) —
Intangible asset impairment (2) 2,540 —
Tax effect of remeasurement and impairment 142 —
Tax effect of revaluation of deferred tax amounts (3) — 16,343
Non-GAAP net income attributable to Central Garden & Pet $43,661 $55,138
GAAP diluted net income per share $0.76 $1.36
Non-GAAP diluted net income per share $0.75 $1.05
Shares used in GAAP and non-GAAP diluted net earnings per share calculation 58,013 52,693

39

Organic Net Sales Reconciliation

We have provided organic net sales, a non-GAAP measure that excludes the impact of recent acquisitions and dispositions, because we believe it permits investors to better understand the performance of our historical business. We define organic net sales as net sales from our historical business derived by excluding the net sales from businesses acquired or exited in the preceding 12 months. After an acquired business has been part of our consolidated results for 12 months, the change in net sales thereafter is considered part of the increase or decrease in organic net sales.

GAAP to Non-GAAP Reconciliation (in millions) For the Three Months Ended March 30, 2019 Consolidated Percent change Pet Segment Percent change Garden Segment Percent change
Reported net sales - Q2 FY19 (GAAP) $673.7 $338.2 $335.5
Reported net sales - Q2 FY18 (GAAP) 613.1 321.7 291.4
Increase in net sales 60.6 9.9% 16.5 5.1% 44.1 15.1%
Effect of acquisition and divestitures on increase in net sales 47.6 16.3 31.3
Increase in organic net sales - Q2 2019 $13.0 2.1% $0.2 0.1% $12.8 4.4%
GAAP to Non-GAAP Reconciliation (in millions) For the Six Months Ended March 30, 2019 Consolidated Percent change Pet Segment Percent change Garden Segment Percent change
Reported net sales - Q2 FY19 YTD (GAAP) $1,135.7 $678.6 $457.1
Reported net sales - Q2 FY18 YTD (GAAP) 1,055.1 646.7 408.4
Increase in net sales 80.6 7.6% 31.9 4.9% 48.7 11.9%
Effect of acquisition and divestitures on increase in net sales 74.9 33.5 41.4
Increase (decrease) in organic net sales - Q2 2019 YTD $5.7 0.5% $(1.6) (0.2)% $7.3 1.8%

40

EBITDA Reconciliation GAAP to Non-GAAP Reconciliation (in thousands, except per share amounts) For the Three Months Ended March 30, 2019 Garden Pet Corp Total
Net income attributable to Central Garden & Pet — — — $42,391
Interest expense, net — — — 8,385
Other income — — — (500)
Income tax expense — — — 11,546
Net income attributable to noncontrolling interest — — — 331
Sum of items below operating income — — — 19,762
Income (loss) from operations $53,355 $26,984 $(18,186) $62,153
Depreciation & amortization 2,312 8,039 1,526 11,877
EBITDA $55,667 $35,023 $(16,660) $74,030
EBITDA Reconciliation GAAP to Non-GAAP Reconciliation (in thousands, except per share amounts) For the Three Months Ended March 31, 2018 Garden Pet Corp Total
Net income attributable to Central Garden & Pet — — — $45,234
Interest expense, net — — — 9,882
Other income — — — (1,505)
Income tax expense — — — 11,643
Net income attributable to noncontrolling interest — — — 532
Sum of items below operating income — — — 20,552
Income (loss) from operations $50,746 $32,784 $(17,744) $65,786
Depreciation & amortization 1,707 6,944 2,471 11,122
EBITDA $52,453 $39,728 $(15,273) $76,908
EBITDA Reconciliation GAAP to Non-GAAP Reconciliation (in thousands, except per share amounts) For the Six Months Ended March 30, 2019 Garden Pet Corp Total
Net income attributable to Central Garden & Pet — — — $44,194
Interest expense, net — — — 16,462
Other income — — — (308)
Income tax benefit — — — 11,819
Net income attributable to noncontrolling interest — — — 167
Sum of items below operating income — — — 28,140
Income (loss) from operations $48,718 $56,739 $(33,123) $72,334
Depreciation & amortization 5,138 16,095 2,996 24,229
EBITDA $53,856 $72,834 $(30,127) $96,563

41

EBITDA Reconciliation GAAP to Non-GAAP Reconciliation (in thousands, except per share amounts) For the Six Months Ended March 31, 2018 Garden Pet Corp Total
Net income attributable to Central Garden & Pet — — — $71,481
Interest expense, net — — — 17,100
Other income (expense) — — — 1,584
Income tax benefit — — — (2,593)
Net income attributable to noncontrolling interest — — — 735
Sum of items below operating income — — — 16,826
Income (loss) from operations $53,046 $68,960 $(33,699) $88,307
Depreciation & amortization 3,276 14,089 4,920 22,285
EBITDA $56,322 $83,049 $(28,779) $110,592

Inflation

Our revenues and margins are dependent on various economic factors, including rates of inflation, energy costs, consumer attitudes toward discretionary spending, currency fluctuations, and other macro-economic factors which may impact levels of consumer spending. In certain fiscal periods, we have been adversely impacted by rising input costs related to domestic inflation, particularly relating to grain and seed prices, fuel prices and the ingredients used in our garden controls and fertilizer. Rising costs in those periods have made it difficult for us to increase prices to our retail customers at a pace sufficient to enable us to maintain margins.

During fiscal 2018, costs increased in a number of areas, including raw materials, freight and labor. We took certain pricing actions, which generally became effective in January 2019, to offset the impact of these inflationary pressures and plan to do so in the year ahead as well.

Weather and Seasonality

Our sales of lawn and garden products are influenced by weather and climate conditions in the different markets we serve. Additionally, our Garden segment’s business is highly seasonal. In fiscal 2018, approximately 68% of our Garden segment’s net sales and 57% of our total net sales occurred during our second and third fiscal quarters. Substantially all of the Garden segment’s operating income is typically generated in this period, which has historically offset the operating loss incurred during the first fiscal quarter of the year.

Liquidity and Capital Resources

We have financed our growth through a combination of internally generated funds, bank borrowings, supplier credit, and sales of equity and debt securities to the public.

Our business is seasonal and our working capital requirements and capital resources track closely to this seasonal pattern. Generally, during the first fiscal quarter, accounts receivable reach their lowest level while inventory, accounts payable and short-term borrowings begin to increase. During the second fiscal quarter, receivables, accounts payable and short-term borrowings increase, reflecting the build-up of inventory and related payables in anticipation of the peak lawn and garden selling season. During the third fiscal quarter, inventory levels remain relatively constant while accounts receivable peak and short-term borrowings start to decline as cash collections are received during the peak selling season. During the fourth fiscal quarter, inventory levels are at their lowest, and accounts receivable and payables are substantially reduced through conversion of receivables to cash.

We service two broad markets: pet supplies and lawn and garden supplies. Our pet supplies businesses involve products that have a year round selling cycle with a slight degree of seasonality. As a result, it is not necessary to maintain large quantities of inventory to meet peak demands. Our lawn and garden businesses are highly seasonal with approximately 68% of our Garden segment’s net sales occurring during the second and third fiscal quarters. This seasonality requires the shipment of large quantities of product well ahead of the peak consumer buying periods. To encourage retailers and distributors to stock large quantities of inventory, industry practice has been for manufacturers to give extended credit terms and/or promotional discounts.

Operating Activities

Net cash used by operating activities decreased by $14.7 million, from $94.0 million of cash used for the six months ended March 31, 2018, to $79.3 million of cash used for the six months ended March 30, 2019. The decrease in cash used was due primarily to changes in our working capital accounts for the period ended March 30, 2019, as compared to the prior year period.

Investing Activities

Net cash used in investing activities decreased $62.1 million, from $89.7 million for the six months ended March 31, 2018 to $27.6 million during the six months ended March 30, 2019. The decrease in cash used in investing activities was due primarily to decreased investment and acquisition activity as well as lower capital expenditures in the current year compared to the prior year. During the second quarter of fiscal 2019, we acquired the remaining 55% interest in Arden Companies for approximately $11 million. During the second quarter of fiscal 2018, we acquired Bell Nurseries for approximately $62 million. Furthermore, during the six months ended March 30, 2019, we made fewer investments and capital expenditures than in the comparable prior year period.

Financing Activities

Net cash provided by financing activities decreased $325.0 million, from $284.7 million of cash provided for the six months ended March 31, 2018, to $40.3 million of cash used for the six months ended March 30, 2019. The decrease in cash provided by financing activities during the current year was due primarily to our December 2017 issuance of $300 million aggregate principal amount 5.125% senior notes due February 2028, partially offset by deferred financing costs of approximately $4.8 million associated with this issuance. Additionally, we repaid approximately $36 million of acquired long-term debt subsequent to our acquisition of Arden Companies during the six months ended March 30, 2019.

We expect that our principal sources of funds will be cash generated from our operations and, if necessary, borrowings under our $400 million asset backed revolving credit facility. Based on our anticipated cash needs, availability under our asset backed revolving credit facility and the scheduled maturity of our debt, we believe that our sources of liquidity should be adequate to meet our working capital, capital spending and other cash needs for at least the next 12 months. However, we cannot assure you that these sources will continue to provide us with sufficient liquidity and, should we require it, that we will be able to obtain financing on terms satisfactory to us, or at all.

We believe that cash flows from operating activities, funds available under our asset backed loan facility, and arrangements with suppliers will be adequate to fund our presently anticipated working capital and capital expenditure requirements for the foreseeable future. We anticipate that our capital expenditures, which are related primarily to replacements and expansion of and upgrades to plant and equipment and also investment in our continued implementation of a scalable enterprise-wide information technology platform, will be approximately $40 million in fiscal 2019.

As part of our growth strategy, we have acquired a number of companies in the past, and we anticipate that we will continue to evaluate potential acquisition candidates in the future. If one or more potential acquisition opportunities, including those that would be material, become available in the near future, we may require additional external capital. In addition, such acquisitions would subject us to the general risks associated with acquiring companies, particularly if the acquisitions are relatively large.

At March 30, 2019, our total debt outstanding was $697.8 million, as compared with $691.1 million at March 31, 2018.

Senior Notes

$300 Million 5.125% Senior Notes

On December 14, 2017, we issued $300 million aggregate principal amount of 5.125% senior notes due February 2028 (the "2028 Notes"). We expect to use the net proceeds from the offering to finance future acquisitions and for general corporate purposes.

We incurred approximately $4.8 million of debt issuance costs in conjunction with this transaction, which included underwriter fees and legal, accounting and rating agency expenses. The debt issuance costs are being amortized over the term of the 2028 Notes.

The 2028 Notes require semiannual interest payments on February 1 and August 1, commencing August 1, 2018. The 2028 Notes are unconditionally guaranteed on a senior basis by our existing and future domestic restricted subsidiaries who are borrowers under or guarantors of our senior secured revolving credit facility or who guarantee the 2023 Notes.

We may redeem some or all of the 2028 Notes at any time, at our option, prior to January 1, 2023 at the principal amount plus a “make whole” premium. At any time prior to January 1, 2021, we may also redeem, at our option, up to 35% of the original aggregate principal amount of the notes with the proceeds of certain equity offerings at a redemption price of 105.125% of the principal amount of the notes. We may redeem some or all of the 2028 Notes, at our option, at any time on or after January 1, 2023 for 102.563%, on or after January 1, 2024 for 101.708%, on or after January 1, 2025 for 100.854% and on or after January 1, 2026 for 100.0%, plus accrued and unpaid interest.

The holders of the 2028 Notes have the right to require us to repurchase all or a portion of the 2028 Notes at a purchase price equal to 101% of the principal amount of the notes repurchased, plus accrued and unpaid interest upon the occurrence of a change of control.

The 2028 Notes contain customary high yield covenants, including covenants limiting debt incurrence and restricted payments, subject to certain baskets and exceptions. We were in compliance with all financial covenants as of March 30, 2019.

$400 Million 6.125% Senior Notes

In November 2015, we issued $400 million aggregate principal amount of 6.125% senior notes due November 2023 (the "2023 Notes"). In December 2015, we used the net proceeds from the offering, together with available cash, to redeem our $400 million aggregate principal amount of 8.25% senior subordinated notes due March 1, 2018 (the "2018 Notes") at a price of 102.063% of the principal amount and to pay fees and expenses related to the offering.

We incurred approximately $6.3 million of debt issuance costs in conjunction with these transactions, which included underwriter fees and legal, accounting and rating agency expenses. The debt issuance costs are being amortized over the term of the 2028 Notes.

The 2023 Notes require semiannual interest payments on May 15 and November 15. The 2023 Notes are unconditionally guaranteed on a senior basis by each of our existing and future domestic restricted subsidiaries which are borrowers under or guarantors of our senior secured revolving credit facility. The 2023 Notes are unsecured senior obligations and are subordinated to all of our existing and future secured debt, including our Credit Facility, to the extent of the value of the collateral securing such indebtedness.

We may redeem some or all of the 2023 Notes at any time, at our option, on or after November 15, 2018 for 104.594%, on or after November 15, 2019 for 103.063%, on or after November 15, 2020 for 101.531% and on or after November 15, 2021 for 100%, plus accrued and unpaid interest.

The holders of the 2023 Notes have the right to require us to repurchase all or a portion of the 2023 Notes at a purchase price equal to 101% of the principal amount of the notes repurchased, plus accrued and unpaid interest upon the occurrence of a change of control.

The 2023 Notes contain customary high yield covenants, including covenants limiting debt incurrence and restricted payments, subject to certain baskets and exceptions. We were in compliance with all financial covenants as of March 30, 2019.

Asset-Based Loan Facility Amendment

In April 2016, we entered into an amended and restated credit agreement which provides up to a $400 million principal amount senior secured asset-based revolving credit facility, with up to an additional $200 million principal amount available with the consent of the Lenders if we exercise the accordion feature set forth therein (collectively, the “Credit Facility”). The Credit Facility matures on April 22, 2021. We may borrow, repay and reborrow amounts under the Credit Facility until its maturity date, at which time all amounts outstanding under the Credit Facility must be repaid in full. As of March 30, 2019, there were no borrowings outstanding and no letters of credit outstanding under the Credit Facility. There were other letters of credit of $8.2 million outstanding as of March 30, 2019.

The Credit Facility is subject to a borrowing base, calculated using a formula based upon eligible receivables and inventory, minus certain reserves and subject to restrictions. As of March 30, 2019, the borrowing base and remaining borrowing availability was $374.0 million. Borrowings under the Credit Facility bear interest at an index based on LIBOR or, at the option of the Company, the Base Rate (defined as the highest of (a) the SunTrust prime rate, (b) the Federal Funds Rate plus 0.5% and (c) one-month LIBOR plus 1.00%), plus, in either case, an applicable margin based on our consolidated senior leverage ratio. Such applicable margin for LIBOR-based borrowings fluctuates between 1.25% - 1.5%, and was 1.25% as of March 30, 2019, and such applicable margin for Base Rate borrowings fluctuates between 0.25% - 0.5%, and was 0.25% as of March 30, 2019. As of March 30, 2019, the applicable interest rate related to Base Rate borrowings was 5.8%, and the applicable interest rate related to LIBOR-based borrowings was 3.8%.

We incurred approximately $1.2 million of debt issuance costs in conjunction with this transaction, which included underwriter fees, legal and accounting expenses. The debt issuance costs will be amortized over the term of the Credit Facility.

The Credit Facility contains customary covenants, including financial covenants which require us to maintain a minimum fixed charge coverage ratio of 1.00:1.00 upon reaching certain borrowing levels. The Credit Facility is secured by substantially all of our assets. We were in compliance with all financial covenants under the Credit Facility during the period ended March 30, 2019.

Off-Balance Sheet Arrangements

There have been no material changes to the information provided in our Annual Report on Form 10-K for the fiscal year ended September 29, 2018 regarding off-balance sheet arrangements.

Contractual Obligations

There have been no material changes outside the ordinary course of business in our contractual obligations set forth in the Management’s Discussion and Analysis of Financial Condition and Results of Operations - Liquidity and Capital Resources in our Annual Report on Form 10-K for the fiscal year ended September 29, 2018.

New Accounting Pronouncements

Refer to Footnote 1 in the notes to the condensed consolidated financial statements for new accounting pronouncements.

Critical Accounting Policies, Estimates and Judgments

There have been no material changes to our critical accounting policies, estimates and assumptions or the judgments affecting the application of those accounting policies since our Annual Report on Form 10-K for the fiscal year ended September 29, 2018.

Market risk

As filed, 164 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There has been no material change in our exposure to market risk from that discussed in our Annual Report on Form 10‑K for the fiscal year ended September 29, 2018.

Controls and procedures

As filed, 1,468 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

(a) Evaluation of Disclosure Controls and Procedures. Our Chief Executive Officer and principal financial officer have reviewed, as of the end of the period covered by this report, the “disclosure controls and procedures” (as defined in the Securities Exchange Act of 1934 Rules 13a-15(e) and 15d-15(e)) that ensure that information relating to the Company required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported in a timely and proper manner and that such information is accumulated and communicated to our management, including our Chief Executive Officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure. Based upon this review, such officers concluded that our disclosure controls and procedures were effective as of March 30, 2019.

(b) Changes in Internal Control Over Financial Reporting. Our management, with the participation of our Chief Executive Officer and our principal financial officer have evaluated whether any change in our internal control over financial reporting occurred during the second quarter of fiscal 2019. Based on that evaluation, management concluded that there has been no change in our internal control over financial reporting during the second quarter of fiscal 2019 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Risk factors

As filed, 848 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There have been no material changes from the risk factors previously disclosed in Item 1A to Part I of our Form 10-K for the fiscal year ended September 29, 2018, except as set forth below.

Our success depends upon our retaining and recruiting key personnel.

Our performance is substantially dependent upon the continued services of our senior management team. The loss of the services of these persons could have a material adverse effect on our business. In February 2019, George C. Roeth, our President and Chief Executive Officer, announced his intent to retire in September 2019. Our future performance depends on our ability to attract and retain skilled employees, including a new Chief Executive Officer. We cannot assure you that we will be able to retain our existing personnel or attract additional qualified employees in the future.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2019-03-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2018-12-30 to 2019-03-30$673.7mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue6 months2018-09-30 to 2019-03-30$1.14bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2018-12-30 to 2019-03-30$467.6mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue6 months2018-09-30 to 2019-03-30$799.5mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2018-12-30 to 2019-03-30$206.1mus-gaap:GrossProfit
Gross profit6 months2018-09-30 to 2019-03-30$336.2mus-gaap:GrossProfit
Selling, general and administrative3 months2018-12-30 to 2019-03-30$143.9mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2018-09-30 to 2019-03-30$263.9mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2018-12-30 to 2019-03-30$62.2mus-gaap:OperatingIncomeLoss
Operating income6 months2018-09-30 to 2019-03-30$72.3mus-gaap:OperatingIncomeLoss
Interest expense3 months2018-12-30 to 2019-03-30$10.6mus-gaap:InterestExpense
Interest expense6 months2018-09-30 to 2019-03-30$21.3mus-gaap:InterestExpense
Income tax3 months2018-12-30 to 2019-03-30$11.5mus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2018-09-30 to 2019-03-30$11.8mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2018-12-30 to 2019-03-30$42.4mus-gaap:NetIncomeLoss
Net income6 months2018-09-30 to 2019-03-30$44.2mus-gaap:NetIncomeLoss
Diluted EPS3 months2018-12-30 to 2019-03-30$0.73us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2018-09-30 to 2019-03-30$0.76us-gaap:EarningsPerShareDiluted
Basic EPS3 months2018-12-30 to 2019-03-30$0.74us-gaap:EarningsPerShareBasic
Basic EPS6 months2018-09-30 to 2019-03-30$0.78us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2018-12-30 to 2019-03-3058,026,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2018-09-30 to 2019-03-3058,013,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2018-09-30 to 2019-03-30−$79.3mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2018-09-30 to 2019-03-30$14.3mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases6 months2018-09-30 to 2019-03-30$3.7mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2019-03-30$329.7mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2019-03-30$1.35bnus-gaap:AssetsCurrent
Total assetsAt period end2019-03-30$2.05bnus-gaap:Assets
Current liabilitiesAt period end2019-03-30$299.1mus-gaap:LiabilitiesCurrent
Long-term debtAt period end2019-03-30$692.6mus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2019-03-30$5.1mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2019-03-30$998.7mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0000887733-19-000007. Last ingested by Listed: Nov 10, 2026, 04:49 ET. Listed shows no prices and gives no investment advice.